TGA Approval

SYMTUZA 800/150/200/10 darunavir/cobicistat/emtricitabine/tenofovir alafenamide 800/150/200/10 mg film-coated tablets (312623)

ARTG ID

312623

ARTG Name

SYMTUZA 800/150/200/10 darunavir/cobicistat/emtricitabine/tenofovir alafenamide 800/150/200/10 mg film-coated tablets

Sponsor

Janssen-Cilag Pty Ltd

ARTG Date

November 22, 2019

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Janssen-Cilag Pty Ltd

Sponsor Item Name

JANSSEN-CILAG PTY LTD

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-CMI-02281-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-02280-1

Active Ingredients

Ingredient Name

cobicistat

Ingredient Name

darunavir

Ingredient Name

emtricitabine

Ingredient Name

tenofovir alafenamide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

AI-Powered Research

Premium Access

SYMTUZA 800/150/200/10 darunavir/cobicistat/emtricitabine/tenofovir alafenamide 800/150/200/10 mg film-coated tablets (312623)

Sponsor Information

Product Information

Consumer Medicine Information

Product Information

Active Ingredients

MedPath

Product

Company

Legal